O'Shea, a professor in the Department of Cell & Developmental Biology and director of the U-M Pluripotent Stem Cell Research Lab, and McInnis, the Upjohn Woodworth Professor of Bipolar Disorder and Depression in the Department of Psychiatry, are
co-senior authors of the new paper.
«What we've done is exciting because there is potential for BanLec to develop into a broad spectrum antiviral agent, something that is not clinically available to physicians and patients right now,» says David Markovitz, M.D.,
co-senior author of the new paper and a professor of internal medicine at the University of Michigan Medical School.
Not exact matches
We wanted to understand what types
of differences are always there, what is causing them, and what they mean,» says Juan Carlos Izpisua Belmonte, a professor in Salk's Gene Expression Laboratory and
co-senior author, with Kelly Frazer
of the University
of California, San Diego, on the
new paper, which was published in Cell Stem Cell in April 2017.